Prof. Dr. Argyris Tzouvelekis | Respiratory | Best Researcher Award
Prof. Dr. Argyris Tzouvelekis | Respiratory | Department of Respiratory Medicine at University Of Patras | Greece
Prof. Dr. Argyris Tzouvelekis is a highly accomplished academic and clinician in the field of Respiratory Medicine, currently serving as Associate Professor at the University of Patras, Greece, and widely recognized for his influential contributions to idiopathic pulmonary fibrosis, interstitial lung diseases, and precision medicine. With a strong academic foundation supported by a Ph.D. in medical sciences, he has consistently demonstrated a rigorous and innovative approach to translational research that bridges molecular mechanisms with patient-centered therapies. His professional experience reflects a balance of clinical excellence, academic leadership, and international collaboration, which has positioned him as one of the leading voices in respiratory medicine worldwide. Prof. Dr. Argyris Tzouvelekis has dedicated his career to unraveling complex disease mechanisms, validating biomarkers, and designing innovative therapeutic interventions, as evidenced by his leadership in clinical trials and prospective studies on lung fibrosis and autoimmune-associated interstitial lung diseases. His research interests extend to exploring shared pathogenic mechanisms between pulmonary fibrosis and lung cancer, applying systems biology to respiratory disorders, and advancing the role of precision medicine in complex lung diseases. His skills span experimental design, clinical trial management, biomarker validation, advanced molecular biology, and data analysis, while his ability to lead interdisciplinary teams and cultivate global networks highlights his reputation as both a researcher and mentor. Prof. Dr. Argyris Tzouvelekis has published extensively in internationally reputed journals such as Nature Medicine, Chest, Annals of the Rheumatic Diseases, and American Journal of Respiratory and Critical Care Medicine, with over 6,900 citations, an h-index of 45, and an i10-index of 92, underscoring the impact and reach of his scholarly output. His awards and honors include recognition for his pioneering clinical and translational research, invitations to participate in international conferences, and active memberships in respected professional organizations such as the European Respiratory Society, where his contributions to advancing respiratory health and science are widely acknowledged. Throughout his career, he has been deeply committed to mentoring young researchers and physicians, strengthening academic training, and contributing to medical education at both national and international levels.
Academic Profile: ORCID | Scopus | Google Scholar
Selected Publications:
-
Inhibition and role of let-7d in idiopathic pulmonary fibrosis – 2010 – Citations: 603
-
Thyroid hormone inhibits lung fibrosis in mice by improving epithelial mitochondrial function – 2018 – Citations: 334
-
A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis – 2013 – Citations: 306
-
Pulmonary autotaxin expression contributes to the pathogenesis of pulmonary fibrosis – 2012 – Citations: 286